PT-141 + Oxytocin Nasal Formulation

PT-141 + Oxytocin Nasal Formulation

• PT-141: 10 mg
• Oxytocin: 5 mg

This precisely formulated nasal presentation combines two compounds that act through distinct neuroendocrine signaling systems.

PT-141, also known as bremelanotide, is a melanocortin receptor agonist with biologically relevant activity at central MC4 receptors. Unlike compounds that act primarily through peripheral vascular pathways, PT-141 has been studied for its action within central nervous system pathways related to sexual response.

Oxytocin is an endogenous neuropeptide that interacts with oxytocin receptors in central and peripheral tissues and participates in neuroendocrine pathways associated with social bonding, emotional processing and reproductive physiology.

The nasal presentation provides a convenient delivery format for individualized protocols established and monitored by a qualified healthcare professional.

Why Merrootlab?

• Precisely defined dual-compound formulation
• PT-141 10 mg + Oxytocin 5 mg
• High-purity ingredients
• Documented characterization and batch-level traceability
• Quality-controlled production and handling
• International shipping with carefully managed packaging
• Professional logistics designed to protect stability and product integrity

For professional use under qualified medical supervision. Individual response, suitability and protocol must be evaluated clinically.